MedTrace Logo

Autologous ADMSC Transplantation in Patients With POI

NCT06132542 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-11-15

No results posted yet for this study

Summary

The primary ovarian insufficiency (premature ovarian failure, premature ovarian insufficiency, premature menopause) is a hypergonadotropic hypogonadism, that failure of the ovarian function in woman younger than 40 years. Fat derived stem cells are mainly mesenchymal stem cells and found to be effective treatment in joint and bone regeneration.

We are planning to investigate the effectiveness of adipose stem cell on ovarian tissue regeneration for patients with premature ovarian failure.

Conditions

  • Premature Ovarian Failure

Interventions

BIOLOGICAL

stem cell therapy

The fat derived stem cell will be transplanted by a reproductive gynecologist who does routine ovarian puncture.

Sponsors & Collaborators

  • Mongolian National University of Medical Sciences

    lead OTHER

Principal Investigators

  • Batsuren Choijamts, Ph.D · Mnums

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2024-10-15
Completion
2024-12-15

Countries

  • Mongolia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06132542 on ClinicalTrials.gov